ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0148

Dysferlin Associated Autoinflammatory Disease Causing Systemic Inflammation and Sterile Lung Abcesses Through Impaired Efferocytosis

Farzana Bhuyan1, Adriana Almeida de Jesus2, Clinton Bradfield3, Mohammad Arif Rahman4, Andre Rastegar3, sundar ganesan3, Sachin Gaurav3, Sara Alehashemi3, Ronit Herzog5, Steven Holland3, Deborah Consilini6, Iain Fraser3 and Raphaela Goldbach-Mansky7, 1National Institutes of Health, Bethesda, MD, 2NIAID, NIH, Silver Spring, MD, 3NIAID, Bethesda, MD, 4NCI, Bethesda, MD, 5Langone Medical Center, New York, NY, 6Nemours Children's Hospital-Delaware, Wilmington, DE, 7NIAID, NIH, Rockville

Meeting: ACR Convergence 2022

Keywords: Autoinflammatory diseases, Inflammasome, innate immunity, macrophages

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 12, 2022

Title: Miscellaneous Rheumatic and Inflammatory Diseases Poster I

Session Type: Poster Session A

Session Time: 1:00PM-3:00PM

Background/Purpose: Using whole exome sequencing (WES), we identified a de novo mutation in DYSF encoding dysferlin in 2 unrelated patients with systemic inflammation and sterile pulmonary abscesses. Unlike dysferlin mutations that cause muscular dystrophies, the patients have no muscle disease, but a robust clinical response to IL-1 blockade suggested inflammasome activation and the presentation with sterile pulmonary abscess formation raised questions about an efferocytosis defect

Methods: We characterized monocytes and neutrophil activation and function to assess the mechanism of the IL-1 dependent inflammation by flowcytometry, immunofluoroscence, ELISA, cytokine array, survival assay and we developed an efferocytosis assay. U937 cells expressing mutant cell line was used to further understand the mutation.

Results: Monocyte and monocyte-derived M1 and M2 macrophages (MDM) stimulated with LPS and ATP-released high IL-1 serum levels, that was higher in the DYSF patients’ monocytes and M1 and M2 MDM compared to healthy controls (HC), and was comparable to the augmented IL-1 production in NOMID. Dysferlin colocalizes with NLRP3 in LPS activated monocyte and in M1 and M2 MDMs. Expression levels of ASC, and Caspase-1 were increased in the DYSF patients monocytes. M2-MDMs from both patients expressed proinflammatory mediators, high CXCL1(P< 0.05), CCL2, IL-6 and IL-8. We observed LPS and ATP activation-induced altered nucleur integrity in M2-MDMs from both patients (70% and 50% respectively) compared to healthy controls. In neutrophils, LPS and ATP activation did not increase IL-1b was not upregulated although MIF, IL-16 and IL-8 levels were observed. We hypothesized that either delayed neutrophil apoptosis or clearence contribute to the lung abscess formation. While neutrophil apoptosis was normal, patients’ M2 MDM ability to clear healthy control neutrophils by efferocytosis was significantly impaired. Coculturing patients’ neutrophils with macrophages from healthy donors didn’t result in abnormal effereocytosis, thus suggesting an efferocytosis defect caused by mutant monocyte derived macrophages. The abnormal efferocyutosis was reproduced in dysferlin nutant U937 cells which showed a defect in phagosome maturation.

Conclusion: The de novo GOF mutation in dysferlin in two patients with systemic inflammation and sterile lung abscesses reveal a novel role of dysferlin in regulating inflammasome activation in monocytes and macrophage maturation and in neutriophil efferocytosis. Our data expand on a previously unidentified role of dysferlin in regulating M2-macrophage efferocytosis of neutrophils as a mechanisms for lung abscess formation.


Disclosures: F. Bhuyan, None; A. Almeida de Jesus, None; C. Bradfield, None; M. Rahman, None; A. Rastegar, None; s. ganesan, None; S. Gaurav, None; S. Alehashemi, None; R. Herzog, None; S. Holland, None; D. Consilini, None; I. Fraser, None; R. Goldbach-Mansky, None.

To cite this abstract in AMA style:

Bhuyan F, Almeida de Jesus A, Bradfield C, Rahman M, Rastegar A, ganesan s, Gaurav S, Alehashemi S, Herzog R, Holland S, Consilini D, Fraser I, Goldbach-Mansky R. Dysferlin Associated Autoinflammatory Disease Causing Systemic Inflammation and Sterile Lung Abcesses Through Impaired Efferocytosis [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/dysferlin-associated-autoinflammatory-disease-causing-systemic-inflammation-and-sterile-lung-abcesses-through-impaired-efferocytosis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/dysferlin-associated-autoinflammatory-disease-causing-systemic-inflammation-and-sterile-lung-abcesses-through-impaired-efferocytosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology